Poseida Therapeutics, Inc. Business Operations Contracts & Agreements
4 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Collaboration and License Agreement, by and between the Registrant and Xyphos Biosciences, Inc. dated April 30, 2024 (Filed With SEC on August 5, 2024)
- Second Amendment to the Collaboration and License Agreement, dated February 7, 2024, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on May 14, 2024)
- First Amendment to the Collaboration and License Agreement, dated November 7, 2023, by and among the Registrant, F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc (Filed With SEC on March 7, 2024)
- Collaboration and License Agreement, by and between the Registrant and Takeda Pharmaceuticals USA, Inc., effective October 11, 2021 (Filed With SEC on March 10, 2022)
